In vivo modeling of prodromal stage of Parkinson's disease

被引:5
|
作者
Cerri, Silvia [1 ]
Blandini, Fabio [1 ,2 ]
机构
[1] IRCCS Mondino Fdn, Lab Cellular & Mol Neurobiol, Via Mondino 2, I-27100 Pavia, Italy
[2] Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy
关键词
Parkinson's disease; Animal models; Prodromal; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MPTP; DOPAMINERGIC-NEURONS; NIGROSTRIATAL NEURODEGENERATION; ALPHA-SYNUCLEINOPATHY; ANIMAL-MODELS; MOUSE MODEL; RAT MODEL; MICE; IMPAIRMENTS; MODULATION;
D O I
10.1016/j.jneumeth.2020.108801
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Parkinson's disease (PD) has a long prodromal period that precedes the appearance of typical motor symptoms. This phase is extremely heterogeneous and is characterized by a wide range of non-motor alterations including REM sleep behavior disorders, constipation, olfactory and urinary dysfunctions. The increasing clinical and experimental knowledge on prodromal PD has led to the development of novel animal models recapitulating this disease stage as well as to a new use and interpretation of existing models. Prodromal animal models of PD represent an important tool for testing new therapeutic strategies and shedding light on the early pathogenic steps that set the ground for the extensive dopaminergic cell death observed in the midbrain. This review summarizes the new insights that these models have provided into the comprehension of a complex and still unexplored stage of PD.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Neuropsychological impairment in prodromal Parkinson's disease
    Pausch, Christoph
    Schomburg, Robert
    Wagenpfeil, Stefan
    Wollenweber, Frank Arne
    Bayer, Caroline
    Fassbender, Klaus
    Behnke, Stefanie
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2016, 371 : 117 - 120
  • [22] Animal Model for Prodromal Parkinson's Disease
    Taguchi, Tomoyuki
    Ikuno, Masashi
    Yamakado, Hodaka
    Takahashi, Ryosuke
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (06)
  • [23] Biofluid Biomarkers in Prodromal Parkinson's Disease
    Mollenhauer, B.
    Chahine, L.
    Dakna, M.
    Bartl, M.
    Siderowf, A.
    Hutten, S. J.
    Merchant, K.
    Marek, K.
    Galasko, D.
    MOVEMENT DISORDERS, 2021, 36 : S339 - S339
  • [24] Tracking the course of prodromal Parkinson's disease
    Breen, David P.
    Lang, Anthony E.
    BRAIN, 2017, 140 (02) : 259 - 262
  • [25] Risk Disclosure in Prodromal Parkinson's Disease
    Schaeffer, Eva
    Toedt, Inken
    Koehler, Susanne
    Rogge, Annette
    Berg, Daniela
    MOVEMENT DISORDERS, 2021, 36 (12) : 2833 - 2839
  • [26] Tracking the course of prodromal Parkinson's disease
    Breen, David P.
    Lang, Anthony E.
    BRAIN, 2017, 140 : 259 - 262
  • [27] Psychiatric Symptoms in Prodromal Parkinson's Disease
    Schneider, R. B.
    Richard, I. H.
    MOVEMENT DISORDERS, 2016, 31 (09) : E12 - E12
  • [28] Prodromal features of Parkinson's disease in women
    Hughes, K.
    Gao, X.
    Baker, J.
    Stephen, C.
    Kim, I.
    Valeri, L.
    Schwarzschild, M.
    Ascherio, A.
    MOVEMENT DISORDERS, 2018, 33 : S357 - S358
  • [29] Prodromal Parkinson Disease
    Postuma, Ronald
    ANNALS OF NEUROLOGY, 2023, 94 : S277 - S277
  • [30] Disentangling prodromal from non-prodromal symptoms of Parkinson's disease
    Jackson, H.
    Anzures-Cabrera, J.
    Simuni, T.
    Postuma, R.
    Pagano, G.
    MOVEMENT DISORDERS, 2021, 36 : S419 - S420